Clinical Trials Directory

Trials / Terminated

TerminatedNCT01615926

Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients

Assessment of The Clinical Course of Dyspnea and Its Association With Respiratory Rate in Patients With Acute Heart Failure Syndromes

Status
Terminated
Phase
Study type
Observational
Enrollment
16 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute heart failure (AHF) is defined as a gradual or rapid change in heart failure (HF) signs and symptoms, such as shortness of breath (also called dyspnea or breathlessness), leg swelling, fatigue, breathlessness with exertion, trouble sleeping flat at night, and weight gain resulting in a need for urgent therapy. AHF results in over 1 million hospitalizations every year, resulting in an enormous public health burden. Approximately 1/3rd of patients will either be re-hospitalized or die within three months, and the resultant financial costs are large. As such, improving outcomes for AHF patients is critically important. Shortness of breath is the most common reason why patients with AHF present to the ER. As such, understanding how severe this symptom is, how much it improves with current treatments is very important to both patients and physicians. The purpose of this study is to determine the degree to which your shortness of breath improves during the first few days of hospitalization and its association with how fast you are breathing.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2012-06-11
Last updated
2013-05-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01615926. Inclusion in this directory is not an endorsement.